Digital Waiting Rooms: Powering the Last Mile of Clinical Research with Real-World Data and Artificial Intelligence
The integration of digital technology is transforming clinical research, improving the efficiency of trial design and execution. A key innovation in this space is the digital waiting room, which leverages real-world data (RWD) and artificial intelligence (AI) to...
Breaking Down SCOPE 2025: What’s Next for Clinical Trials?
SCOPE 2025, held from February 3-6 in Orlando, Florida, brought together over 4,500 leaders in clinical operations and research to discuss the latest advancements in clinical trial innovation, planning, management, and operations. The TriNetX team was in full force,...
TriNetX and Fujitsu Launch Joint Venture to Increase Japanese Patients’ Access to Life-Changing Medicines
Partnership taps real-world data to accelerate clinical trials, research, and drug development in Japan. Cambridge, MA, February 12, 2025 — TriNetX, a global leader in real-world data (RWD) and real-world evidence (RWE) solutions, has partnered with Fujitsu,...
The Impact of Responsible AI on Healthcare: Challenges and Opportunities Ahead
Key takeaways: AI’s ability to quickly analyze and integrate vast, diverse data, identify patterns, and make accurate predictions presents significant opportunities in clinical research and drug development. Advanced analytics, predictive modeling, and machine...
Monitoring Potential Adverse Drug Events: Why Real-World Data is Key to Drug Safety
Adverse Drug Events (ADEs) or Adverse Drug Reactions (ADRs) continue to be a concern both in new and existing medicines. According to Medication Safety Data published by the U.S. Centers for Disease Control and Prevention (CDC), ADEs cause more than 1.5 million...
Real-World Data: Opening New Doors in Oncology Research and Patient Care
In the dynamic world of healthcare, real-world data (RWD) and the real-world evidence (RWE) derived from it stand as a crucial pillar for informed insights and actions. No where is this more evident than in oncology, where RWD and RWE are delivering on four key...
SCOPE 2025: Putting Patients at the Heart of Research
Clinical trials are the bedrock of medical advancement, but they often grapple with a persistent challenge: ensuring diverse and representative participation. This issue isn’t just a matter of ethics—it’s crucial for delivering effective, equitable healthcare...
TriNetX’s Founding CEO Announces Plans to Step Down
After 11 Years, Gadi Lachman to Conclude Operating Role, Remain on TriNetX’s Board CAMBRIDGE, MA – January 9, 2025 – TriNetX, the largest global source of real-world data, today announced that Gadi Lachman, the Company’s Founder, President and CEO, will step...